DAB.bio

About

DAB.bio, or Delft Advanced Biofuels, is a biotechnology company based in Delft, Netherlands. Founded in 2012 as a spinout from TU Delft, the company specializes in fermentation technology aimed at producing chemicals, fuels, and proteins from renewable sources. The core of DAB.bio's offering is its patented FAST (extractive fermentation) platform. This innovative bioreactor and process design allows for in-situ product removal directly from the reactor, significantly lowering operational and capital costs in biomanufacturing. DAB.bio operates as a technology licensing company, collaborating with partners to support the production of biomaterials and promote sustainable manufacturing practices. The company has successfully raised $2.24 million in Series A funding, attracting investment from various deep tech funds.